Latest Breaking News On - Chimerixannounced wednesday - Page 1 : comparemela.com

The company’s first-in-class small molecule imipridone, ONC201, showed strong efficacy results in two early-stage clinical trials of 71 pediatric patients with H3K27M-mutant diffuse midline gliomas.

United statesMike andrioleCarl koschmannSriram vennetiChimerixannounced wednesdayCancer discoveryChad carr pediatric brain tumor centerMichigan medicineHimerixs drug candidate improves survival for patients with incurable brain tumor